Build an FDA-Cleared DFU Healing-Potential Predictor

1. 1

   Define the predictive endpoint

   Fix exactly what the tool predicts and the clinical decision it informs, for example whether a wound will close 50 percent by week four, an endpoint a documented cleared platform forecasts with about 86 percent accuracy. The endpoint must be clinically meaningful and measurable, because your entire trial and clearance are built around it. A vague prediction target cannot be validated or cleared.

2. 2

   Develop the imaging or measurement technology

   Predicting healing potential typically requires capturing objective wound data (for example specialized imaging of tissue characteristics), so develop or license the measurement technology plus the predictive model. The technology and model together are the product. Design them under quality controls from the start, since this is a regulated medical device, not a research prototype.

3. 3

   Plan and run the clinical trials

   FDA clearance for a predictive diagnostic requires clinical evidence, so design and run the trials that demonstrate the predictive accuracy and clinical utility of the tool. This is the longest and most expensive part, often years and substantial funding. Engage regulatory and clinical-trial experts early, because trial design determines whether the evidence will actually support clearance.

4. 4

   Secure FDA clearance

   Work through the appropriate FDA pathway to clearance, framing the product as clinical decision support: it gives clinicians an objective, immediate healing-potential assessment, and a licensed clinician remains responsible for the treatment decision. Clearance is the asset that makes the business defensible and credible to buyers. Budget the time and cost of the regulatory process realistically.

5. 5

   Sell objective, immediate decision support

   Your buyers are wound-care centers, health systems, and podiatry groups that gain from earlier, evidence-based treatment decisions and potentially reduced visit frequency and better patient satisfaction. Sell the specific gap you fill: an objective healing forecast that did not previously exist. A cleared, validated tool commands trust and pricing that unvalidated software cannot.

6. 6

   Deploy, support, and monitor

   Post-clearance, integrate into wound-care workflows, support the installed base, and maintain post-market surveillance and any consumables or service revenue. Feed real-world results back into improvements within your regulatory obligations. This card explains the business; imaging development, clinical trials, and FDA clearance require specialized regulatory, clinical, and legal advisers, and the AI supports, not replaces, licensed clinical judgment.

Do not take our word for the money. Put your own numbers in and see what this idea has to earn before it works. Free, instant, no account needed.